McBride (LON:MCB - Get Free Report) is set to announce its Final earnings results after the market closes on Tuesday, October 8th.
Shares of MCB stock traded down GBX 0.50 ($0.01) on Monday, reaching GBX 116 ($1.52). 130,070 shares of the company's stock were exchanged, compared to its average volume of 346,367. The company's fifty day simple moving average is GBX 124.08 and its 200 day simple moving average is GBX 120.47. McBride has a 52 week low of GBX 31.40 ($0.41) and a 52 week high of GBX 145 ($1.90). The company has a current ratio of 0.92, a quick ratio of 0.54 and a debt-to-equity ratio of 222.08. The stock has a market capitalization of £201.29 million, a PE ratio of 610.53, a P/E/G ratio of -0.36 and a beta of 1.17.
In other McBride news, insider Alastair S. N. Murray bought 20,000 shares of the business's stock in a transaction on Wednesday, September 25th. The shares were acquired at an average price of GBX 118 ($1.54) per share, with a total value of £23,600 ($30,886.01). In related news, insider Mark Strickland sold 113,846 shares of the company's stock in a transaction on Friday, September 20th. The stock was sold at an average price of GBX 116 ($1.52), for a total transaction of £132,061.36 ($172,832.56). Also, insider Alastair S. N. Murray acquired 20,000 shares of the company's stock in a transaction that occurred on Wednesday, September 25th. The shares were bought at an average cost of GBX 118 ($1.54) per share, for a total transaction of £23,600 ($30,886.01). 5.78% of the stock is owned by insiders.
McBride plc, together with its subsidiaries, manufactures and sells private label household and personal care products to retailers and brand owners in the United Kingdom, Germany, France, Australia, rest of Europe, rest of Asia-Pacific, and internationally. The company operates through five segments: Liquids, Powders, Unit dosing, Aerosols, and Asia Pacific.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider McBride, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and McBride wasn't on the list.
While McBride currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.